Newsfeeds - Spark Newswire

1 minute read

Northland Capital Markets Maintains Outperform on Sangoma Technologies, Lowers Price Target to $13

Today, 10:03 PM

Northland Capital Markets analyst Michael Latimore maintains Sangoma Technologies (NASDAQ:SANG) with a Outperform and lowers the price target from $15 to $13.

SANG

1 minute read

Canaccord Genuity Maintains Buy on Sangoma Technologies, Lowers Price Target to $12

By Benzinga Newsdesk

Today, 10:03 PM

Canaccord Genuity analyst Robert Young maintains Sangoma Technologies (NASDAQ:SANG) with a Buy and lowers the price target from $13 to $12.

SANG

4 minute read

Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 10:03 PM

Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursday. SeqLL recently announced the establishment of a two-year Cooperative Research and Development Agreement with the U.S. Department of Justice's Federal Bureau of Investigation.

$APE

11 minute read

Earnings

Earnings Scheduled For February 9, 2023

By Benzinga Insights

Today, 10:03 PM

Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.

ABBV

5 minute read

Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:03 PM

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on Iberian Airlines' in-flight magazine, Ronda.

2 minute read

Analyst Ratings

Canaccord Genuity Maintains Buy Rating for Sangoma Technologies: Here’s What You Need To Know

By Benzinga Insights

Today, 10:03 PM

Canaccord Genuity has decided to maintain its Buy rating of Sangoma Technologies (NASDAQ:SANG) and lower its price target from $21.00 to $13.00. Shares of Sangoma Technologies are trading down 0.18% over the last 24 hours, at $5.54 per share.

SANG

1 minute read

Canaccord Genuity Maintains Buy on Sangoma Technologies, Lowers Price Target to $13

By Benzinga Newsdesk

Today, 10:03 PM

Canaccord Genuity analyst Robert Young maintains Sangoma Technologies (NASDAQ:SANG) with a Buy and lowers the price target from $21 to $13.

SANG

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 22, 2022

By Benzinga Insights

Today, 10:03 PM

Upgrades

5 minute read

77 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:03 PM

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners.

ACOR

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For May 26, 2022

By Benzinga Insights

Today, 10:03 PM

Upgrades

ABC